SAN DIEGO (AP) _ Mirati Therapeutics Inc. (MRTX) on Tuesday reported a loss of $27.6 million in its third quarter.
The San Diego-based company said it had a loss of 85 cents per share.
The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 84 cents per share.
Mirati shares have more than doubled since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $39.15, nearly tripling in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MRTX at https://www.zacks.com/ap/MRTX